Cognitive Neurology Unit Clinical Registry

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Beth Israel Deaconess Medical Center
Study ID
NCT05925621
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 95 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease

Key Dates

Start date
Jul 16, 2023
Status verified
Apr 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Lecanemab
    Patients with Alzheimer Disease receiving anti-amyloid mAb therapy at the BIDMC

Primary Outcome Measure

To Determine Whether Anti-Amyloid Mabs Slow Cognitive And Functional Decline [ Time Frame: 30 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Beth Israel Deaconess Medical CenterBostonMassachusetts02215-

Find similar trials in Boston, MA

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Beth Israel Deaconess Medical Center· Boston, MA

Related Studies